BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 32810885)

  • 1. Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis pneumonia prophylaxis.
    Fu W; Barahona M; Harkness T; Cohen E; Reardon D; Yoo PS
    Clin Transplant; 2020 Nov; 34(11):e14067. PubMed ID: 32810885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.
    Singh R; Bemelman FJ; Hodiamont CJ; Idu MM; Ten Berge IJ; Geerlings SE
    BMC Infect Dis; 2016 Feb; 16():90. PubMed ID: 26912326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
    Prosty C; Katergi K; Sorin M; Rjeily MB; Butler-Laporte G; McDonald EG; Lee TC
    Clin Microbiol Infect; 2024 Jul; 30(7):866-876. PubMed ID: 38583518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of intravenous pentamidine for Pneumocystis jirovecii pneumonia prophylaxis in adult patients with hematologic malignancies-its utility during respiratory virus pandemics.
    Liew YX; Ho AYL; Wong GC; Chung SJ; Tan TT; Tan BH
    Int J Infect Dis; 2024 Jun; 143():107059. PubMed ID: 38615824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors.
    Arnold LM; Hoshina Y; Lee H; Colman H; Mendez J
    J Neurooncol; 2024 Mar; 167(1):211-217. PubMed ID: 38363493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis.
    Passerini M; Nayfeh T; Yetmar ZA; Coussement J; Goodlet KJ; Lebeaux D; Gori A; Mahmood M; Temesgen Z; Murad MH
    Clin Microbiol Infect; 2024 Feb; 30(2):170-177. PubMed ID: 37865337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of effectiveness, hyperkalaemia, and hepatotoxicity of trimethoprim-sulphamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in paediatric patients: A single-centre retrospective study.
    Kato H; Hagihara M; Asai N; Mikamo H; Iwamoto T
    Int J Antimicrob Agents; 2024 May; 63(5):107151. PubMed ID: 38508538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report.
    Baran K; FurmaƄczyk-Zawiska A; Wieczorek-Godlewska R; Nitek P; Durlik M
    Transplant Proc; 2024 May; ():. PubMed ID: 38760300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Epidemiological Analysis of Pneumocystis Jirovecii Pneumonia Infection in Kidney Transplant Patients with Trimethoprim-Sulfamethoxazole Dose Reduction Prophylaxis Strategy.
    Shan W; Wang L; Qin J; Peng W; Ma K
    Infect Drug Resist; 2024; 17():2299-2306. PubMed ID: 38868399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis Pneumonia in Locally Advanced Breast Cancer Despite Prophylactic Use of Trimethoprim-Sulfamethoxazole During Prednisolone Treatment for a Pembrolizumab-Induced Immune-Related Adverse Event: A Case Report.
    Kaneda Y; Gonda K; Asakura T; Wada M; Sawano T; Kurokawa T; Tachibana K; Ozaki A
    Cureus; 2024 Mar; 16(3):e56868. PubMed ID: 38659518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelotoxicity and kidney dysfunction related to the use of trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia: a case report of severe adverse events with a common drug.
    Mendes ICM; Mamani RF; Coelho DRA; Pimentel C
    Rev Inst Med Trop Sao Paulo; 2024; 66():e18. PubMed ID: 38511807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients.
    Skoloda D; Newman M; Norman H; Ziggas JE; Ambinder RF
    JCO Oncol Pract; 2024 May; 20(5):673-677. PubMed ID: 38382007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients.
    Lee JR; Bang H; Dadhania D; Hartono C; Aull MJ; Satlin M; August P; Suthanthiran M; Muthukumar T
    Transplantation; 2013 Oct; 96(8):732-8. PubMed ID: 23917724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV: treating Pneumocystis pneumonia (PCP).
    Bellamy RJ
    BMJ Clin Evid; 2008 Jul; 2008():. PubMed ID: 19445734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfamethoxazole-trimethoprim for pneumocystis pneumonia prophylaxis, causes of discontinuation and thrombocytopenia observed during administration: A single-center retrospective study.
    Hashimoto M; Hiraiwa M; Uchitani K; Ueda M; Tanaka M; Nishiyama N; Miyashita N
    J Infect Chemother; 2024 Feb; 30(2):141-146. PubMed ID: 37797822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim/sulfamethoxazole desensitization in an HIV-positive patient with previous Stevens-Johnson syndrome; a failed study.
    Ansari R; Ghaderkhani S; Namazi S
    Daru; 2023 Jun; 31(1):69-73. PubMed ID: 37002421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycaemia associated with co-trimoxazole use in a 56-year-old Caucasian woman with renal impairment.
    Forde DG; Aberdein J; Tunbridge A; Stone B
    BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23144351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics for UTI Prevention After Intradetrusor OnabotulinumtoxinA Injections.
    Heuer CW; Gisseman JD; Vaccaro CM; Olsen CH; Galgano AC; Dengler KL
    Urogynecology (Phila); 2024 Mar; 30(3):272-279. PubMed ID: 38484242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for urinary tract infection in kidney transplantation from brain death donor and its role in graft function.
    Ye Q; Wu L; Zhu B; Zhang G; Yang B; Jin P; Zhu X; Xie J; Ding X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Nov; 46(11):1220-1226. PubMed ID: 34911856
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.